Management of Amlapitta by Dashanga Ghanavati

Efficacy of Dashanga Ghanavati in the management of Urdhvaga Amlapitta – An open label single blind randomized control clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039302

Enrollment

Registered

2022-01-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Known or newly disease case of Amlapitta along with three or more symptoms of Urdhvaga Amlapitta like Avipaka, Klama, Utklesha, Tiktamla Udgara, Anga Gaurava, Hrit-Kukshi-Kanth Daha, Aruchi, Shirah shool, Tiktamla Vami Bhukte- Vidagdhe-bhukte-Abhukte. Willing to participate in the study / Ready to abide study protocol

Exclusion criteria

Exclusion criteria: Patients below 18 year and above 60 years of age. Patient suffering from gastrointestinal disorders other than Urdhvaga Amlapitta like Peptic ulcer, Duodenal ulcer, Pancreatic disease, hepatic disease, Inflammatory bowel disease, Malignancy of G.I.T Any systemic disease like Diabetes mellitus, uncontrolled hypertension, patients taking NSAIDs. Patients not willing to participate / Not ready to abide study protocol

Design outcomes

Primary

Measure	Time frame
Improvement in symptoms of Urdhvaga AmlapittaTimepoint: 4 weeks	—

Secondary

Measure	Time frame
Improvement in quality of life of the patientTimepoint: 1 MONTH	—

Countries

India

Contacts

Public ContactDR DARSHNA PANDYA

ITRA JAMNAGAR

darshnapandya73@gmail.com9099011095

Outcome results